Up to 85% of people who are clinically blind could benefit.
A brain implant will directly stimulate the V1 visual cortex.
Some of the world’s leading experts in their fields.
Monash Vision Group (MVG) is a collaboration between Monash University, Alfred Health, MiniFAB and Grey Innovation. MVG has two key goals; to develop research capabilities in medical bionics for vision restoration and to produce a cortical prosthetic prototype device that will be demonstrated in at least one recipient by 2014. Many people who are blind or vision impaired have damaged optical nerves, which prevent signals reaching the brain. MVG aims to restore a sense of sight by transmitting wireless signals directly to an implant in the brain. The project is funded through the ARC Research in Bionic Vision Science and Technology Initiative, with funding from 2010-2014. Learn more about the Monash Vision Group.
On behalf of our partners and collaborators, Monash Vision Group would like to acknowledge the significant contribution by Dr Mike Hirshorn to the initiative. Mike served as the Independent Chair of the MVG Advisory Board and Steering Committee between September 2010 and August 2011. With his passion for advancing medical technologies, Mike was instrumental in creating our management ethos and for supporting the consortium from the earliest of stages. Mike is sadly missed by the MVG team and his absence is felt by the Australian biotech community.